| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Dec 18, 2025 | Disc Medicine, Inc. | Director | Sell | 47.5 | -754 | -0.11% | ✗ | $69K |
| Dec 12, 2025 | Dec 16, 2025 | Disc Medicine, Inc. | Director | Sell | 15.0 | -184,123 | -3.72% | ✗ | $16.9M |
| Oct 15, 2025 | Oct 17, 2025 | Disc Medicine, Inc. | Director | Sell | 16.3 | -93,585 | -1.24% | ✗ | $8M |
| Oct 7, 2025 | Oct 9, 2025 | Disc Medicine, Inc. | Director | Sell | 16.3 | -90,000 | -15.24% | ✗ | $6.3M |
| Aug 22, 2025 | Aug 26, 2025 | Disc Medicine, Inc. | Director | Sell | 48.8 | -2,287 | -0.39% | ✓ | $139.6K |
| Aug 13, 2025 | Aug 15, 2025 | Disc Medicine, Inc. | Director | Sell | 27.5 | -32,174 | -5.15% | ✓ | $2M |
| Aug 5, 2025 | Aug 7, 2025 | Disc Medicine, Inc. | Director | Sell | 55.0 | -395 | -0.06% | ✓ | $24.1K |
| Jul 30, 2025 | Aug 1, 2025 | Disc Medicine, Inc. | Director | Sell | 42.5 | -8,492 | -1.34% | ✓ | $518.4K |
| Jul 23, 2025 | Jul 25, 2025 | Disc Medicine, Inc. | Director | Sell | 17.5 | -42,870 | -6.33% | ✗ | $2.6M |
| Jul 18, 2025 | Jul 22, 2025 | Disc Medicine, Inc. | Director | Sell | 51.3 | -664 | -0.10% | ✗ | $40.6K |
| Jun 17, 2024 | Jun 20, 2024 | Disc Medicine, Inc. | Director | Buy | 100.0 | +222,223 | 112.05% | ✗ | $8M |
| Mar 5, 2024 | Mar 7, 2024 | Disc Medicine, Inc. | Director | Sell | 17.5 | -26,157 | -3.72% | ✗ | $1.9M |
| Jan 23, 2024 | Jan 25, 2024 | Disc Medicine, Inc. | Director | Sell | 16.3 | -102,500 | -10.20% | ✗ | $6.9M |
| Jan 10, 2024 | Jan 12, 2024 | Disc Medicine, Inc. | Director | Sell | 17.5 | -20,000 | -2.48% | ✗ | $1.3M |
| Dec 12, 2023 | Dec 14, 2023 | Disc Medicine, Inc. | Director | Sell | 17.5 | -76,064 | -8.62% | ✗ | $4.7M |
| Aug 15, 2023 | Aug 17, 2023 | Disc Medicine, Inc. | Director | Sell | 17.5 | -72,931 | -7.64% | ✗ | $3.8M |
| Jun 1, 2021 | Jun 3, 2021 | Akero Therapeutics, Inc. | Director | Sell | 7.5 | -17,489 | -100.00% | ✓ | $459.6K |
| Oct 9, 2020 | Oct 14, 2020 | Akero Therapeutics, Inc. | Director | Sell | 20.0 | -13,000 | -52.46% | ✗ | $376.1K |
| Jun 24, 2019 | Jun 25, 2019 | Akero Therapeutics, Inc. | Director | Buy | 100.0 | +270,000 | 114.85% | ✗ | $4.3M |
| May 22, 2017 | May 24, 2017 | Editas Medicine, Inc. | Director | Sell | 15.0 | -1,000,000 | -26.34% | ✗ | $17M |
| Dec 7, 2016 | Dec 8, 2016 | Editas Medicine, Inc. | Director | Sell | 17.5 | -75,000 | -1.94% | ✗ | $1.2M |
| Dec 5, 2016 | Dec 7, 2016 | Editas Medicine, Inc. | Director | Sell | 17.5 | -130,000 | -3.25% | ✗ | $2.1M |
| Nov 23, 2016 | Nov 28, 2016 | Editas Medicine, Inc. | Director | Sell | 30.0 | -21,480 | -0.53% | ✗ | $337.5K |
| Nov 22, 2016 | Nov 23, 2016 | Editas Medicine, Inc. | Director | Sell | 40.0 | -12,819 | -0.32% | ✗ | $202.2K |
| Nov 16, 2016 | Nov 18, 2016 | Editas Medicine, Inc. | Director | Sell | 30.0 | -30,830 | -0.76% | ✗ | $502.5K |
| Nov 14, 2016 | Nov 16, 2016 | Editas Medicine, Inc. | Director | Sell | 17.5 | -88,900 | -2.14% | ✗ | $1.5M |
| Sep 8, 2016 | Sep 12, 2016 | Editas Medicine, Inc. | Director | Sell | 16.3 | -500,000 | -10.74% | ✗ | $8.4M |